People with depression face an increased risk of cardiovascular disease (CVD); however, more women experience CVD following a depression diagnosis than men, according to a new study published today in JACC: Asia.
Trailing Akero and 89bio, Boston Pharmaceuticals posts early data on its NASH injection
In an early-stage study, Boston Pharmaceuticals’ injection reduced indicators of NASH, a fatty liver disease. The treatment is one of a handful of investigational drugs
June 22, 2023